Search

everythinglearnresearchcommunity

for

Search:↓

Certain symptoms and patient profiles, like thoracic pain and general malaise, increase the risk of COVID-19 patients being readmitted to the emergency department.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

More research is needed to understand sex and racial differences in long COVID.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

A multidisciplinary approach is crucial for effectively managing hair loss linked to endocrine and gynecological disorders.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

COVID-19 generally causes fewer complications than influenza, except for certain conditions like hair loss and heart issues.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

Chronic tonsillitis is linked to NETosis activity, which may help tailor treatments and reduce tonsil removal surgeries.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Extra virgin olive oil may boost the immune system and help fight infections like COVID-19.

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.

Urban children in western Belarus had more severe COVID-19 cases in 2021.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.